about
An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo and a Currently Available Treatment in Participants With Moderate to Severe Plaque PsoriasisTreatment of Mild to Moderate Distal Subungual Onychomycosis of the ToenailA Study to Explore Efficacy and Safety of ASP015K in Subjects With Moderate to Severe PsoriasisA Study to Evaluate TMI-358 in the Treatment of Distal Subungual OnychomycosisA Bioequivalence Study With Clinical Endpoints Comparing Generic Imiquimod Cream, 3.75% and Zyclara™ (Imiquimod) Cream, 3.75% in Subjects With Actinic KeratosesA Study to Evaluate the Efficacy and Safety of Mirikizumab (LY3074828) in Participants With Moderate-to-Severe Plaque PsoriasisA Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Actinic Keratoses (AKs) on the Non Head LocationsA Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and ScalpShort-incubation Levulan Photodynamic Therapy Versus Vehicle for Face/Scalp Actinic Keratosis (AK)AN2728 Topical Ointment to Treat Mild-to-Moderate Plaque-Type PsoriasisA Study of Lebrikizumab in Patients With Moderate-to-Severe Atopic DermatitisA Study of Ixekizumab (LY2439821) Compared to Guselkumab in Participants With Moderate-to-Severe Plaque PsoriasisA Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia AreataStudy to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring SubjectsStudy to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
P6153
Q61902320-E1B2238D-EF70-4A88-A3C0-0EC95688683EQ61920811-0DC7D538-131D-462C-A824-F785AC489175Q61936502-0DCD0AC8-0BFB-49AE-BA1A-F4E58158B2CAQ61936915-F7830AEE-975F-4A09-B46F-A75CA80C356AQ61957537-BF22C529-A3C8-4DC3-8D26-A897CF042003Q62810949-0DC39DAB-6CE3-47FF-A861-2CDE99116E4AQ63062590-5D830FD2-5081-482D-A837-CBCA421E3809Q63318846-CCAA3DB6-5F33-426E-AD01-C9B21E56CE34Q63320927-86DF4B69-9D80-4D75-A170-76F100C3E0D3Q63338298-FD0CEF9A-2272-4515-B14D-238398CB169FQ63403106-CEAE9F09-417B-4288-A52C-51A98316010DQ63574032-862AE40C-398A-47A8-BDD1-F9B634B1564BQ63574046-C9956D9D-677D-461C-BECC-24EB821A3C9EQ64150432-E79B09DB-1703-47DE-98E2-D6558C3FA506Q64187770-B308FD6E-71B6-4DB1-81E7-6D6B0F9087FD
P6153
description
healthcare organization in Portland, United States
@en
name
Oregon Medical Research Center
@en
type
label
Oregon Medical Research Center
@en
prefLabel
Oregon Medical Research Center
@en
P131
P2427
grid.477719.b
P571
1998-01-01T00:00:00Z
P625
Point (-122.774622 45.447211)